David Dornan is an experienced leader in oncology research and biotechnology. They served as the Director and Head of Oncology Research at Gilead Sciences from 2016 to 2017 and held various senior roles at Bolt Biotherapeutics, including Chief Scientific Officer and Senior Vice President of Research. They currently serve as the Chief Scientific Officer at Whitehawk Therapeutics and as an Independent Board Director at ReviR Therapeutics since 2022. Previously, David was a Senior Scientist at Genentech, working in Molecular Diagnostics and Cancer Cell Biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices